机构地区:[1]The State Key Laboratory of Virology, Department of Immunology and Hubei Province Key Laboratory of Allergy and Immune-related Diseases, Wuhan University School of Medicine, Wuhan 430071, China [2]Center for Disease Control and Prevention of Wuhan, Wuhan 430071, China [3]Division of Allergy-Immunology, the Children's Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA [4]Central Hospital of Enshi Prefecture, Hubei 445000, China [5]These two authors contribute equally to this work as first authors [6]Department of Immunology, Wuhan University School of Medicine, 165 Donghu Road, Wuhan 430071, China
出 处:《Cellular & Molecular Immunology》2009年第4期235-244,共10页中国免疫学杂志(英文版)
基 金:Acknowledgments This work was supported by grants to X.-L. Zhang from the National Natural Science Foundation of China (30870122, 30670098 and 20532020), 973 Program of China 2006CB 504300 and 2009CB522507, National Grand Program on Key Infectious Disease (2008ZX10003-005), Hubei Province Science Technology Department (2006ABD007, 2007ABC 010) and Hubei Ministry of Public Health of (JX1B074).
摘 要:L-ficolin, one of lectin families, is a recently identified complement factor that initiates lectin pathway of complement. Little is known about its role in viral hepatitis. In the present study, we found that L-ficolin in serum from 103 patients with hepatitis C virus (HCV), were significantly higher than that in 150 healthy controls. We further found that L-ficolin expressions were significantly increased in vitro study by HCV JFH-1 infected human hepatocyte cell line Huh7.5.1. Investigation of the mechanisms of the L-ficolin action on HCV demonstrated that L-ficolin protein could recognize and bind to envelope glycoproteins E1 and E2 of HCV, activating the lectin complement pathway-mediated cytolytic activity in HCV-infected hepatocyte. This interaction between L-ficolin and HCV E1 and E2 glycoproteins was attributed to the N-glycans of E1 and E2. These findings provide new insights into the biological functions of L-ficolin in clinically important hepatic viral diseases.L-ficolin, one of lectin families, is a recently identified complement factor that initiates lectin pathway of complement. Little is known about its role in viral hepatitis. In the present study, we found that L-ficolin in serum from 103 patients with hepatitis C virus (HCV), were significantly higher than that in 150 healthy controls. We further found that L-ficolin expressions were significantly increased in vitro study by HCV JFH-1 infected human hepatocyte cell line Huh7.5.1. Investigation of the mechanisms of the L-ficolin action on HCV demonstrated that L-ficolin protein could recognize and bind to envelope glycoproteins E1 and E2 of HCV, activating the lectin complement pathway-mediated cytolytic activity in HCV-infected hepatocyte. This interaction between L-ficolin and HCV E1 and E2 glycoproteins was attributed to the N-glycans of E1 and E2. These findings provide new insights into the biological functions of L-ficolin in clinically important hepatic viral diseases.
关 键 词:L-FICOLIN hepatitis C virus envelope glycoproteins COMPLEMENT viral hepatitis
分 类 号:S852.65[农业科学—基础兽医学] Q78[农业科学—兽医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...